Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Wall Street
Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA
is 1 534.17 INR
with a low forecast of 1 151.4 INR and a high forecast of 1 963.5 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Sun Pharmaceutical Industries Ltd
For the last 8 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's operating income is
4%.
The projected
CAGR
for the next 4 years is
17%.
Net Income
Forecast
Net Income Estimate
Sun Pharmaceutical Industries Ltd
For the last 8 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's net income is
8%.
The projected
CAGR
for the next 4 years is
16%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
1 534.17
INR
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA
is 1 534.17 INR
with a low forecast of 1 151.4 INR and a high forecast of 1 963.5 INR.
What is Sun Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's revenue is
6%.
The projected
CAGR
for the next 4 years is
10%.
What is Sun Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's operating income is
4%.
The projected
CAGR
for the next 4 years is
17%.
What is Sun Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Sun Pharmaceutical Industries Ltd's net income is
8%.
The projected
CAGR
for the next 4 years is
16%.
You don't have any saved screeners yet
